$OSG

OCTAVE SPECIALTY GROUP INC

1
0
0

No SEC Form 4 filings for $OSG in the last 30 days.

See all $OSG insider activity →
Low

Here are Friday's biggest analyst calls: Nvidia, SpaceX, Tesla, Amazon, Marvell, Affirm & more

Analysts made several calls: Stifel initiated The Metals Royalty Company as buy, citing upside potential. Evercore ISI reiterated SpaceX and Nvidia as outperform, highlighting their partnership. CLSA upgraded Baozun to outperform, raising its target to $3.80. Bank of America raised Affirm's target to $104, reiterated Marvell and Tesla as buy, and noted Burlington's market share gains. Evercore ISI raised Amazon's target to $355. KBW initiated Octave Specialty Group as outperform. Argus upgraded

Octave Specialty Group (OSG) Q2 2026 Earnings Call Transcript

Octave Specialty Group (OSG) reported Q2 2026 revenue of $83.0 million, up 51% year over year, driven by its Insurance Distribution segment. Net loss attributable to shareholders was $14.4 million, and adjusted EBITDA was $3.7 million. Management raised 2026 distribution organic growth to 25%+ and adjusted EBITDA to $45 million, but lowered adjusted EPS guidance to $0.15-$0.20 and Everspan adjusted EBITDA to $6 million.

OSG Q2 Earnings Miss Estimates, Revenues Beat on Distribution Growth

Octave Specialty Group (OSG) reported Q2 2026 adjusted loss of 4 cents per share, narrower than a year ago but worse than the Zacks estimate of a 1-cent loss. Revenues rose 51% to $83 million. Insurance Distribution revenue grew 77% to $58.4 million. Management raised 2026 Insurance Distribution outlook, while cutting Everspan EBITDA guidance to $6 million. The article also cites Q2 results for SIGI, AXS, and CINF.

OSG sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning OSG (OCTAVE SPECIALTY GROUP INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent OSG coverage spans earnings, financial news and regulation.

What's driving OSG

  • New coverage could attract investors.

    cnbc.com · Aug 28, 2026

  • Guidance mix is likely to drive near-term sentiment: stronger distribution growth/EBITDA offset by weaker adjusted EPS and lower Everspan EBITDA.

    fool.com · Aug 14, 2026

  • Insurance Distribution momentum drove revenue and EBITDA upside, but Everspan acquisition-cost pressure reduced that segment’s EBITDA outlook and EPS guidance.

    tradingview.com · Aug 10, 2026

  • The filing provides fresh quarterly performance and segment-level profitability trends, plus a new AI underwriting platform update that could affect underwriting speed and margins.

    SEC EDGAR 8-K · Aug 6, 2026

  • Ahead of the Aug. 6 print, the article frames expectations for revenue growth and a small EPS loss, but provides no new guidance beyond consensus.

    tradingview.com · Aug 3, 2026

alphai scores every news story that mentions OSG with an AI model for sentiment and relevance, and aggregates insider trades from OCTAVE SPECIALTY GROUP INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $OSG

Score
$TMCRLow

Here are Friday's biggest analyst calls: Nvidia, SpaceX, Tesla, Amazon, Marvell, Affirm & more

Analysts made several calls: Stifel initiated The Metals Royalty Company as buy, citing upside potential. Evercore ISI reiterated SpaceX and Nvidia as outperform, highlighting their partnership. CLSA upgraded Baozun to outperform, raising its target to $3.80. Bank of America raised Affirm's target to $104, reiterated Marvell and Tesla as buy, and noted Burlington's market share gains. Evercore ISI raised Amazon's target to $355. KBW initiated Octave Specialty Group as outperform. Argus upgraded

$OSGMedAI 8/10

Octave Specialty Group (OSG) Q2 2026 Earnings Call Transcript

Octave Specialty Group (OSG) reported Q2 2026 revenue of $83.0 million, up 51% year over year, driven by its Insurance Distribution segment. Net loss attributable to shareholders was $14.4 million, and adjusted EBITDA was $3.7 million. Management raised 2026 distribution organic growth to 25%+ and adjusted EBITDA to $45 million, but lowered adjusted EPS guidance to $0.15-$0.20 and Everspan adjusted EBITDA to $6 million.

$OSGMedAI 8/10

OSG Q2 Earnings Miss Estimates, Revenues Beat on Distribution Growth

Octave Specialty Group (OSG) reported Q2 2026 adjusted loss of 4 cents per share, narrower than a year ago but worse than the Zacks estimate of a 1-cent loss. Revenues rose 51% to $83 million. Insurance Distribution revenue grew 77% to $58.4 million. Management raised 2026 Insurance Distribution outlook, while cutting Everspan EBITDA guidance to $6 million. The article also cites Q2 results for SIGI, AXS, and CINF.

OCTAVE SPECIALTY GROUP INC (OSG): Results of Operations and Financial Condition

OCTAVE SPECIALTY GROUP INC (OSG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Octave Specialty Group Reports Second Quarter 2026 Results • Insurance Distribution Segment ◦ Total revenue grew 77% to $58 million ◦ Organic revenue growth equaled 44% ◦ Ne t loss to Shareholders totaled $(4) million , compared to $(8) million in 2Q25 ◦ Adjusted EBI

Octave Specialty Group to Report Q2 Earnings: What to Expect

Octave Specialty Group (OSG) is set to report Q2 2026 results on Aug. 6 after the close. Zacks expects revenue of $81 million, up 47.4% year over year, and a Q2 loss of 1 cent per share, improving 95.5%. The article cites OSG’s prior four-quarter earnings beats and discusses drivers such as premiums, fees, and investment income.

Related tickers